The effect of adolescent inhalant abuse on energy balance and growth

Pharmacology Research & Perspectives
Rose CrossinJhodie R Duncan

Abstract

The abuse of volatile solvents such as toluene is a significant public health concern, predominantly affecting adolescents. To date, inhalant abuse research has primarily focused on the central nervous system; however, inhalants also exert effects on other organ systems and processes, including metabolic function and energy balance. Adolescent inhalant abuse is characterized by a negative energy balance phenotype, with the peak period of abuse overlapping with the adolescent growth spurt. There are multiple components within the central and peripheral regulation of energy balance that may be affected by adolescent inhalant abuse, such as impaired metabolic signaling, decreased food intake, altered dietary preferences, disrupted glucose tolerance and insulin release, reduced adiposity and skeletal density, and adrenal hypertrophy. These effects may persist into abstinence and adulthood, and the long-term consequences of inhalant-induced metabolic dysfunction are currently unknown. The signs and symptoms resulting from chronic adolescent inhalant abuse may result in a propensity for the development of adult-onset metabolic disorders such as type 2 diabetes, however, further research investigating the long-term effects of inhalant...Continue Reading

References

Mar 1, 1976·Archives of Disease in Childhood·J M Tanner, R H Whitehouse
Jan 1, 1992·Archives of Toxicology·K AmenoI Ijiri
Sep 1, 1991·The Journal of Clinical Endocrinology and Metabolism·J P BonjourR Rizzoli
Mar 1, 1991·The American Journal of Psychiatry·R J Mathew, W H Wilson
Jan 1, 1989·The Medical Clinics of North America·R E Keesey
May 1, 1986·Neurology·J T HormesN L Rosenberg
Jan 1, 1974·Internationales Archiv Für Arbeitsmedizin·A SatoK Hirosawa
Apr 19, 1973·The New England Journal of Medicine·E P DiMagnoW H Summerskill
Dec 29, 1966·The New England Journal of Medicine·J W Knox, J R Nelson
Jan 1, 1984·International Archives of Occupational and Environmental Health·R B DickV Putz-Anderson
Jan 1, 1983·International Archives of Occupational and Environmental Health·R AnderssonJ Sollenberg
Mar 1, 1982·Scandinavian Journal of Work, Environment & Health·A Carlsson
Apr 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·C W Sharp, C P Freeman
Sep 26, 1996·European Journal of Pharmacology·S E BowenR L Balster
Jan 1, 1997·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M J KretschH L Johnson
Jun 20, 1998·Science·S C WoodsM W Schwartz
Aug 26, 1998·Journal of Toxicology. Clinical Toxicology·Y KamijoT Ohwada
Nov 3, 1998·Brain : a Journal of Neurology·P MaruffJ Currie
May 8, 1999·The American Journal of Physiology·B E LevinV H Routh
Apr 15, 2000·Nature·M W SchwartzD G Baskin
Aug 2, 2000·The American Journal of Clinical Nutrition·A D RogolJ N Roemmich
Feb 28, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·T L KurtzmanR A Wahl
Jan 26, 2002·British Medical Bulletin·C N Hales, D J Barker
Feb 6, 2002·Annals of Internal Medicine·Rob M van DamFrank B Hu
May 28, 2002·Journal of Endocrinological Investigation·E MolinariS Marchi
Sep 6, 2002·European Journal of Endocrinology·M T Muñoz, J Argente
Nov 14, 2002·The Journal of Endocrinology·J CornishI R Reid
May 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mari S GolubAlice F Tarantal
May 20, 2003·Pharmacology & Toxicology·Karin S HougaardSøren P Lund
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A C RiegelE D French
Jun 6, 2003·Lancet·Wiebke Arlt, Bruno Allolio
Jun 28, 2003·Best Practice & Research. Clinical Gastroenterology·Christiane Bode, J Christian Bode
Jul 28, 1962·JAMA : the Journal of the American Medical Association·H H GLASER, O N MASSENGALE
Nov 6, 2003·International Archives of Occupational and Environmental Health·Ari KaukiainenHelena Taskinen
Mar 17, 2004·Neurotoxicology and Teratology·Lena MorónEnrique Echevarría
Feb 17, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sheree CairneyBart J Currie
Jul 22, 2005·Biological Trace Element Research·A Avni AtayErdal Gokcay
Oct 27, 2006·Neurotoxicology and Teratology·Scott E BowenSilvia L Cruz

❮ Previous
Next ❯

Citations

Jun 5, 2021·Neurotoxicology and Teratology·Silvia L Cruz, Scott E Bowen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Paediatrics and Child Health
David Isaacs, Nick Pigott
Lippincott's Primary Care Practice
K Espeland
Minnesota Medicine
J E Huxsahl
Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association
Allison A Muller, Geraldine F Muller
© 2021 Meta ULC. All rights reserved